Every 8-K that Central Garden and Pet Co (CENT) has filed with the SEC in the last 24 months is listed below, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
A 8-K covers material events a company has to report between its quarterly reports, so if you follow CENT and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full CENT filings page.
Central Garden & Pet Company reported fiscal 2026 third-quarter results with net sales of $882 million versus $961 million a year ago, an 8% decline driven by the exit of the pet distribution business. Organic net sales, excluding acquisitions and divestitures, rose 2% to $862 million. Gross margin expanded to 35.9%, and operating income was $126 million versus $135 million. GAAP diluted EPS was $1.45 compared with $1.52, while non-GAAP diluted EPS was $1.54 versus $1.56. Adjusted EBITDA was $162 million with margin improving to 18.3%.
Pet segment net sales were $400 million, down 19% but with 2% organic growth and stronger margins, while Garden segment net sales increased 3% to $482 million and operating income grew 9%. Liquidity remained strong with $997 million of cash and cash equivalents, total debt of about $1.2 billion, gross leverage of 2.8x and net leverage of 0.5x, and $128 million still available for share repurchases.
Following quarter-end, Central agreed to acquire an 80% interest in TRIXIE for €340 million in cash at closing plus up to €60 million in earn-out payments, for total consideration of up to €400 million, with closing expected in the first half of fiscal 2027. Management now expects fiscal 2026 non-GAAP diluted EPS of $2.85 or better, raised from $2.70 or better, and projects about $50 million of capital expenditures for the year.
Central Garden & Pet Company agreed to acquire approximately 80% of TRIXIE Heimtierbedarf GmbH & Co. KG, a leading European pet supplies and snacks provider, under a Sale and Purchase Agreement. Total consideration is up to €400 million, including approximately €340 million in cash at closing and an earn-out of up to €60.0 million based on 2026 performance, each subject to adjustments.
Certain TRIXIE shareholders will retain roughly 20%, with put and call rights over at least three years. Completion is subject to regulatory approval and other customary closing conditions and is expected in the first half of Central’s fiscal year ending September 25, 2027. TRIXIE serves over 30,000 retail stores with more than 6,000 products and employs close to 600 people in a European pet supplies and snacks market of approximately €10 billion in annual sales. Central reported fiscal 2025 net sales of $3.1 billion and states that TRIXIE will operate within its Pet segment, with existing TRIXIE leadership remaining in place to support its European growth strategy.
Central Garden & Pet Company reported record fiscal 2026 second quarter results, with net sales of $906.2 million, up from $833.5 million a year earlier. Gross margin improved to 33.1% and operating income rose to $113.9 million from $93.3 million.
Net income attributable to the company increased to $79.4 million, with diluted EPS of $1.28 versus $0.98. Non-GAAP diluted EPS was $1.29. Adjusted EBITDA reached $139.5 million, compared with $123.3 million. The company reaffirmed its fiscal 2026 non-GAAP diluted EPS outlook of $2.70 or better.
Pet segment net sales grew to $477 million and Garden segment sales to $429 million, both showing higher operating income. Cash and cash equivalents were $653.2 million, total debt was $1.2 billion, and gross leverage was 2.8x, below the 3.0–3.5x target range.
Central Garden & Pet Company appointed longtime executive Kay M. Schwichtenberg to its Board of Directors and Audit Committee, effective March 1, 2026. She brings more than 40 years of animal health experience, including 29 years with the company.
The Compensation Committee set fiscal 2025 cash bonuses and updated total compensation for named executive officers, with CEO Nicholas Lahanas receiving $1,134,000 in non-equity incentive pay and total 2025 compensation of $3,039,762. Base salaries for key executives, including an increase in Mr. Lahanas’s salary to $990,000, became effective January 1, 2026, alongside new restricted stock and stock option grants under the 2003 Omnibus Equity Incentive Plan.
Shareholders elected all director nominees, ratified Deloitte & Touche LLP as auditor, and approved on an advisory basis the executive compensation package. The Board also increased the stock repurchase authorization by $100 million, bringing total authorized repurchases to approximately $127 million with no expiration date.
Central Garden & Pet Company filed a current report to share that it has released its latest quarterly financial results. The company issued a press release covering results for the first quarter of its fiscal year 2026, which ended on December 27, 2025.
The press release, dated February 4, 2026, is included as Exhibit 99.1 to the report. Central Garden & Pet’s common stock (CENT) and Class A common stock (CENTA) are listed on The NASDAQ Stock Market LLC.
Central Garden & Pet Company filed a Form 8-K to report that it has released its financial results for the fourth quarter and fiscal year 2025, which ended on September 27, 2025. The company announced these results in a press release dated November 24, 2025, which is furnished as Exhibit 99.1. The filing is made under the Results of Operations and Financial Condition item and also lists the related interactive data tags for the cover page. Central Garden & Pet’s common stock trades on Nasdaq under the symbols CENT and CENTA.
Central Garden & Pet Company amended and restated its credit facility, entering a Fourth Amended and Restated Credit Agreement for a $600 million senior secured asset-based revolver with an uncommitted $400 million accordion, maturing November 7, 2030.
The borrowing base is determined by eligible receivables and inventory, and, at the Company’s election, eligible real property, less reserves. The Company did not draw at closing; proceeds may be used for general corporate purposes. The facility includes a $50 million letter of credit sublimit and a $75 million short‑notice borrowing sublimit.
Borrowings bear interest at SOFR (floor 0.00%) or a defined Base Rate, plus a margin tied to average availability. At closing, the applicable margin was 1.00% for SOFR loans and 0.00% for Base Rate loans. Covenants include a minimum fixed charge coverage ratio of 1.00:1.00 when triggered. The facility is secured by substantially all assets, including pledges of domestic and certain foreign subsidiary equity.